Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression

Neuroscience

Volumn 158, Issue 3, 2009, Pages 1098-1111

  Offner, H ^a,b   Vandenbark, A A ^a,b   Hurn, P D ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

immunosuppression; macrophages; spleen; stroke; Treg cells

Indexed keywords

BRAIN ANTIGEN; CD11B ANTIGEN; CHEMOKINE; CYTOKINE; TRANSCRIPTION FACTOR FOXP3;

ANTIGENICITY; B LYMPHOCYTE; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL COUNT; CELL DEATH; CELL LOSS; CELL MOTILITY; CELL SPECIFICITY; CELLULAR IMMUNITY; CIRCULATION; CONVALESCENCE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; EXPERIMENTAL STUDY; HUMAN; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; LYMPH NODE; MACROPHAGE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; REVIEW; SEPTICEMIA; SPLEEN; SPLEEN CELL; STROKE; SURVIVOR; T LYMPHOCYTE; THYMUS;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; MICE; RATS; SPLEEN; STROKE;

EID: 59349116941     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.05.033     Document Type: Review

References (62)

1. Ajmo C.T., Vernon D.O.L., Collier L., Hall A.A., Garbuzova-Davis S., Willing A., and Pennypacker K.R. The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res (2008) published online: April 1 2008 DOI: 10.1002/jnr.21661
2. Allan S.M., and Rothwell N.J. Cytokine and acute neurodegeneration. Nat Rev 2 (2001) 734-744
3. Allan S.M., and Rothwell N.J. Inflammation in central nervous system injury. Phil Trans R Soc Lond 358 (2003) 1669-1677
4. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: New opportunities for novel therapies. J Cereb Blood Flow Metab 19 (1999) 819-834
5. Becker K.J., McCarron R.M., Ruetzler C., Laban O., Sternberg E., Flanders K.C., and Hallenbeck J.M. Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci U S A 94 (1997) 10873-10878
6. Becker K.J., Kindrick D., Relton J., Harlan J., and Winn R. Antibody to the α4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32 (2001) 206-211
7. Belkaid Y., Piccirillo C.A., Mendez S., Shevach E.M., and Sachs D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
8. Cartier L., Hartley O., Dubois-Dauphin M., and Krause K.-H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Rev 48 (2005) 16-42
9. Chamorro A., Urra X., and Plana A.M. Infection after acute ischemic stroke. A manifestation of brain-induced immunodepression. Stroke 38 (2007) 1097-1103
10. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., Hill J.K., Stenzel-Poore M.P., and Eckenstein F. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31 (2000) 1715-1720
11. del Zoppo G.J., Becker K.J., and Hallenbeck J.M. Inflammation after stroke: Is it harmful?. Arch Neurol 58 (2001) 669-672
12. Dirnagl U., Klehmet J., Braun J.S., Harms H., Meisel C., Ziemssen T., Prass K., and Meisel A. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38 (2007) 770-773
13. Emsley H.C.A., Smith C.J., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., Hallenbeck J.M., del Zoppo G.J., Rothwell N.J., Tyrrell P.J., and Hopkins S.J. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139 (2003) 93-101
14. Emsley H.C.A., Smith C.J., Gavin C.M., Georgiou R.F., Vail A., Marmeran E.M., Illingworth K., Scarth S., Wickramasinghe V., Hoadley M.E., Rothwell N.J., Tyrrell P.J., and Hopkins S.J. Clinical outcome following acute ischaemic stroke related to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 7 (2007) 5
15. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
16. Gendron A., Teitelbaum J., Cossette C., Nuara S., Dumont M., Geadah D., du Souch P., and Kouassi E. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 955 (2002) 85-97
17. Haeusler K.G., Schmidt W.U.H., Fohring F., Meisle C., Helms T., Jungehulsing G.J., Nolte C.H., Schmolke K., Wegner B., Meisel A., Dirnagl U., Villringer A., and Volk H. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 25 (2008) 50-58
18. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., and Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 20 (2000) 6421-6430
19. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor, Foxp3. Science 299 (2003) 1057-1061
20. Hurn P.D., Subramanian S., Parker S.M., Afentoulis M.E., Kaler L.J., Vandenbark A.A., and Offner H. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 27 (2007) 1798-1805
21. Jander S., Karemer M., Schroeter M., Witte O.W., and Stoll G. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 15 (1995) 42-51
22. Khattri R., Cox T., Yasayko S., and Ramsdell F. An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4 (2003) 337-342
23. Kim J.S., Gautam S.C., Chopp M., Zaloga C., Jones M.L., Ward P.A., and Welch K.M.A. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J Neuroimmunol 56 (1995) 127-134
24. Kipnis J., Mizrahi T., Hauben E., Shaked I., Shevach E., and Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci U S A 99 (2002) 15620-15625
25. Kohm A.P., and Sanders V.M. Norepinephrin and B2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53 (2001) 487-525
26. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.F. Tumor necrosis factor α expression in ischemic neurons. Stroke 25 (1994) 1481-1488
27. Liu T., McDonnell P.C., White R.F., Barone F.C., and Feuerstein G.F. Interleukin-1B mRNA expression in ischemic rat cortex. Stroke 24 (1993) 1746-1751
28. Maloy K.J., and Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2 (2001) 816-822
29. Mason D., and Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 10 (1998) 649-655
30. Meisel C., Schwab J.M., Prass K., Meisel A., and Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev 6 (2005) 775-786
31. Meyer S., Stritmatter M., Fischer C., Georg T., and Schmitz B. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport 15 (2004) 357-361
32. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., and Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5 (1999) 49-55
33. Nadareishvili Z.G., Li H., Wright V., Maric D., Warach S., Hallenbeck J.M., Dambrosia J., Barker J.L., and Baird A.E. Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death. Neurology 63 (2004) 1446-1451
34. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Vandenbark A.A., and Hurn P.D. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 26 (2006) 654-665
35. Offner H., Subramanian S., Parker S.M., Wang C., Afentoulis M.E., Lewis A., Vandenbark A.A., and Hurn P.D. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176 (2006) 6523-6531
36. O'Neill L.A., and Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20 (1997) 252-258
37. Polanczyk M.J., Hopke C., Vandenbark A.A., and Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res 84 (2006) 370-378
38. Prass K., Ruscher K., Karsch M., Isaev N., Megow D., Priller J., Scharff A., Dirnagl U., and Meisel A. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22 (2002) 520-525
39. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., and Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198 (2003) 725-736
40. Relton J.K., Sloan K.E., Frew E.M., Whalley E.T., Adams S.P., and Lobb R.R. Inhibition of α4 integrin protects against transient focal cerebral ischemia in normotensive and hypertensive rats. Stroke 32 (2001) 199-205
41. Roncarolo M.G., and Levings M.K. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12 (2000) 676-683
42. Sakaguchi S., and Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 24 (2005) 211-226
43. Schroeter M., Jander S., Witte O.W., and Stoll G. Local immune responses in the rat middle cerebral artery occlusion. J Neuroimmunol 55 (1994) 195-203
44. Shevach E.M. Regulatory T cells in autoimmunity. Annu Rev Immunol 18 (2000) 423-449
45. Shimizu J., Yamazaki S., and Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163 (1999) 5211-5218
46. Smith C.J., Emsley H.C.A., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., del Zoppo G.J., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., and Tyrrell P.J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4 (2004) 2
47. Spleiss O., Gourmala N., Boddeke H., Sauter A., Fiebich B.L., Berger M., and Gebicke-Haertere P.J. Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of mRNA in ischemic and endotoxinemic rat brain. J Neurosci Res 53 (1998) 15-28
48. Stevens S.L., Bao J., Hollis J., Lessov N.S., Clark W.M., and Stenzel-Poore M.P. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 932 (2002) 110-119
49. Stoll G. Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia. Rev Neurol 158 (2002) 887-891
50. Swanson M.A., Lee W.T., and Sanders V.M. IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. J Immunol 166 (2001) 232-240
51. Takami S., Minami M., Nagata I., Namura S., and Satoh M. Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21 (2001) 1430-1435
52. Takami S., Minami M., Katayama T., Nagata I., Namura S., and Satoh M. TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 22 (2002) 780-784
53. Vogelgesang A., Grunwald U., Langner S., Jack R., Broker B.M., Kessler C., and Dressel. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39 (2008) 237-241
54. Vollenweider F., Herrmann M.M., and Otten U. Interleukin-6 expression and localization after transient global ischemia in gerbil hippocampus. Neurosci Lett 341 (2003) 49-52
55. Wang X.K., Yue T.-L., Barone F.C., White R.F., Young P.R., McDonnell P.C., and Feuerstein G.Z. Concomitant cortical expression of TNFα and IL-1B mRNA following transient focal ischemia. Mol Chem Neuropathol 23 (1994) 103-114
56. Wang X.K., Yue T.-L., Barone F.C., and Feuerstein G.F. Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in rat ischemic cortex. Stroke 26 (1995) 661-666
57. Wang X.K., Yue T.-L., Young P.R., Barone F.C., and Feuerstein G.Z. Expression of interleukin-6, c-fos and zif268 mRNA in rat ischemic cortex. J Cereb Blood Flow Metab 15 (1995) 166-171
58. Wang X.K., Barone F.C., Aiyar N.V., and Feuerstein G.F. Increased interleukin-1 receptor and interleukin-1 receptor antagonist gene expression after focal stroke. Stroke 28 (1997) 155-162
59. Wang X.K., Ellison J.A., Siren A.-L., Lysko P.G., Yue T.-L., Barone F.C., Shatzman A., and Feuerstein G.F. Prolonged expression of interferon inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in the rat. J Neurochem 71 (1998) 1194-1204
60. Wang X., Schmidt D.B., Foley J.J., Barone F.C., Ames R.S., and Sarau H.M. Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Mol Pharmacol 57 (2000) 1190-1198
61. Yilmaz G., Arumugam T.V., Stokes K.Y., and Granger D.N. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113 (2006) 2105-2112
62. Zheng Z., and Yenari M.A. Ischemic inflammation: molecular mechanisms and therapeutic implications. Neurological Res 26 (2004) 884-892